Svenungsson B, Bengtsson E, Fluur E, Siegborn J
Scand J Infect Dis. 1976;8(3):175-80. doi: 10.3109/inf.1976.8.issue-3.10.
20 patients with Haemophilus influenzae meningitis who had been treated with chloramphenicol over the period 1959-1970 and 23 patients who had been treated with ampicillin over the period 1968-1974 were re-examined by hearing tests in 1975. In all the cases the two agents had been given initially by the parenteral route, chloramphenicol in doses varying between 50 and 150 (averaging 101) mg/kg/day and ampicillin in doses varying between 125 and 350 (averaging 229) mg/kg/day. Five of the 20 patients in the chloramphenicol group were found to be deaf on one ear, whereas 1 of the 23 patients in the ampicillin group was completely deaf. A further 3 in the chloramphenicol group and 1 in the ampicillin group had slight sensorineural hearing loss on one ear. Only in 2 of the 6 deaf patients was the loss discovered during the time of hospital care. The present study has not provided any evidence supporting the recently reported observation (Gamstorp and Klockhoff, 1974) that the frequency of hearing loss might be higher after ampicillin than after chloramphenicol treatment for H. influenzae meningitis.
1975年,对1959年至1970年间接受氯霉素治疗的20例流感嗜血杆菌脑膜炎患者和1968年至1974年间接受氨苄西林治疗的23例患者进行了听力测试复查。所有病例中,两种药物最初均通过肠胃外途径给药,氯霉素剂量为50至150(平均101)mg/kg/天,氨苄西林剂量为125至350(平均229)mg/kg/天。氯霉素组的20例患者中有5例被发现单耳失聪,而氨苄西林组的23例患者中有1例完全失聪。氯霉素组另有3例和氨苄西林组1例单耳有轻微感音神经性听力损失。6例失聪患者中只有2例是在住院治疗期间发现听力损失的。本研究没有提供任何证据支持最近报道的观察结果(甘斯托普和克洛科夫,1974年),即流感嗜血杆菌脑膜炎患者接受氨苄西林治疗后听力损失的发生率可能高于接受氯霉素治疗后。